ATE288080T1 - Methode zur identifikation von modulatoren von neuromediatoren - Google Patents

Methode zur identifikation von modulatoren von neuromediatoren

Info

Publication number
ATE288080T1
ATE288080T1 AT00958662T AT00958662T ATE288080T1 AT E288080 T1 ATE288080 T1 AT E288080T1 AT 00958662 T AT00958662 T AT 00958662T AT 00958662 T AT00958662 T AT 00958662T AT E288080 T1 ATE288080 T1 AT E288080T1
Authority
AT
Austria
Prior art keywords
neuromediators
modulate
neurotransmitters
nerve tissue
compounds
Prior art date
Application number
AT00958662T
Other languages
English (en)
Inventor
L Maurice Isra
Bernard Lesbats
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE288080T1 publication Critical patent/ATE288080T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9406—Neurotransmitters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70571—Assays involving receptors, cell surface antigens or cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
AT00958662T 1999-08-11 2000-08-10 Methode zur identifikation von modulatoren von neuromediatoren ATE288080T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9910410A FR2797453B1 (fr) 1999-08-11 1999-08-11 Procede d'identification de composes capables de moduler la liberation de neuromediateur et les kits pour sa mise en oeuvre
PCT/FR2000/002294 WO2001013108A1 (fr) 1999-08-11 2000-08-10 Procede d'identification de composes modulateurs des neuromediateurs

Publications (1)

Publication Number Publication Date
ATE288080T1 true ATE288080T1 (de) 2005-02-15

Family

ID=9549085

Family Applications (2)

Application Number Title Priority Date Filing Date
AT03007646T ATE315227T1 (de) 1999-08-11 2000-08-10 Verfahren zum auffinden von verbindungen, die als modulatoren von neuromediatoren fungieren
AT00958662T ATE288080T1 (de) 1999-08-11 2000-08-10 Methode zur identifikation von modulatoren von neuromediatoren

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT03007646T ATE315227T1 (de) 1999-08-11 2000-08-10 Verfahren zum auffinden von verbindungen, die als modulatoren von neuromediatoren fungieren

Country Status (9)

Country Link
US (1) US7279330B1 (de)
EP (2) EP1203233B1 (de)
JP (1) JP2003507710A (de)
AT (2) ATE315227T1 (de)
AU (1) AU776373B2 (de)
CA (1) CA2381700A1 (de)
DE (2) DE60025405T2 (de)
FR (1) FR2797453B1 (de)
WO (1) WO2001013108A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4665165B2 (ja) * 2005-03-31 2011-04-06 国立大学法人富山大学 生体アミンの分析方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992019717A1 (en) * 1991-04-02 1992-11-12 Baylor College Of Medicine A high-affinity human glutamate/aspartate uptake system

Also Published As

Publication number Publication date
EP1335202B1 (de) 2006-01-04
AU7011100A (en) 2001-03-13
EP1203233A1 (de) 2002-05-08
US7279330B1 (en) 2007-10-09
FR2797453B1 (fr) 2003-10-17
DE60025405T2 (de) 2006-09-07
JP2003507710A (ja) 2003-02-25
CA2381700A1 (fr) 2001-02-22
AU776373B2 (en) 2004-09-09
EP1203233B1 (de) 2005-01-26
ATE315227T1 (de) 2006-02-15
FR2797453A1 (fr) 2001-02-16
WO2001013108A1 (fr) 2001-02-22
DE60017754T2 (de) 2006-01-05
EP1335202B9 (de) 2006-06-28
DE60025405D1 (de) 2006-03-30
EP1335202A1 (de) 2003-08-13
DE60017754D1 (de) 2005-03-03

Similar Documents

Publication Publication Date Title
EA199801044A1 (ru) Модуляторы регенерации тканей
EA200000298A1 (ru) Агонисты простагландинов и их применение для лечения заболеваний костей
ATE279181T1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
BR9712085A (pt) Inibidores de metaloprotease heterocìclicos
DE69839815D1 (de) Verwendung von ppar-gamma aktivatoren zur behandlung von hautkrankheiten
NO944997D0 (no) Trombin-blodfraksjon for anvendelse ved en medisinsk fremgangsmåte
DE69821011D1 (de) Verfahren zur modulierung der neovaskularisierung und/oder des wachstums von kollateraler arterien und / oder anderer arterien aus bestehenden arteriolären verbindungen
AU2987695A (en) Interruption of binding of mdm2 and p53 protein and therapeutic application thereof
DE69637800D1 (de) Verbindungen zur Behandlung der ischaemischen Gewebe
EA199900494A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
BR0108977A (pt) Compostos azacìclicos para uso no tratamento de doenças relaciondas com serotonina
BR9811948A (pt) Secretores de hormÈnio do crescimento
ATE413176T1 (de) Verwendung von 1-azabicyclo(2.2.2)octan-3-on- derivaten zur behandlung von krebstumoren
BR9713178A (pt) Inbidores espirocìclicos da metaloprotease.
EP1098642A4 (de) Verfahren zur behandlung von zustanden moduliert durch lactosylceramiden
ATE461707T1 (de) Pharmazeutische verbindung und methoden zur behandlungen von menschliche karzinome mittels arginin entzug
ATE439833T1 (de) Pharmazeutische zubereitung enthaltend ein catechin, ascorbinsäure, prolin und lysin zur behandlung von neoplastischen krankheiten
MXPA00006306A (es) Compuestos del canal de ion del cerebro o corazon, regulados por nucleotidos ciclicos y usos de los mismos.
DE69725882D1 (de) Adenovirus e4 proteine für induktion von zelltod
BR0111158A (pt) Composto e sais fisiológicos do mesmo, método para tratar uma condição mediana por tnf-a em um paciente
NO974260L (no) Nye definerte enzymblandinger for oppnåelse av celler og behandling av sår
ATE350032T1 (de) Verwendung der protein-kinase-c-epsilon- inhibitoren zur behandlung von schmerzen
ATE313334T1 (de) Behandlung von tumoren mit photodynamischer therapie
IL143516A0 (en) COMPOUNDS AND METHODS FOR MODULATING ACTIVATION OF NF-k-B
DE69912743D1 (de) Behandlung von follikulären lymphomen unter verwendung von inhibitoren des lymphotoxin (lt)-aktivierungsweges

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties